These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 28730692

  • 1. Self-perception of voice in transgender persons during cross-sex hormone therapy.
    Bultynck C, Pas C, Defreyne J, Cosyns M, den Heijer M, T'Sjoen G.
    Laryngoscope; 2017 Dec; 127(12):2796-2804. PubMed ID: 28730692
    [Abstract] [Full Text] [Related]

  • 2. Associations between the Transsexual Voice Questionnaire (TVQMtF ) and self-report of voice femininity and acoustic voice measures.
    Dacakis G, Oates J, Douglas J.
    Int J Lang Commun Disord; 2017 Nov; 52(6):831-838. PubMed ID: 28425220
    [Abstract] [Full Text] [Related]

  • 3. Organizing the voice questionnaire for transgender persons.
    Bultynck C, Pas C, Defreyne J, Cosyns M, T'Sjoen G.
    Int J Transgend Health; 2020 Nov; 21(1):89-97. PubMed ID: 33005904
    [Abstract] [Full Text] [Related]

  • 4. Transsexual Voice Questionnaire for Male-to-female Brazilian Transsexual People.
    Schwarz K, Fontanari AMV, Mueller A, Costa AB, Soll B, da Silva DC, Cielo CA, Kuhl G, Spritzer PM, Schneider MA, Dorfmann ME, Lobato MIR.
    J Voice; 2017 Jan; 31(1):120.e15-120.e20. PubMed ID: 27146028
    [Abstract] [Full Text] [Related]

  • 5. Further Evidence of the Construct Validity of the Transsexual Voice Questionnaire (TVQMtF) Using Principal Components Analysis.
    Dacakis G, Oates JM, Douglas JM.
    J Voice; 2017 Mar; 31(2):142-148. PubMed ID: 27515560
    [Abstract] [Full Text] [Related]

  • 6. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.
    Smith KP, Madison CM, Milne NM.
    Pharmacotherapy; 2014 Dec; 34(12):1282-97. PubMed ID: 25220381
    [Abstract] [Full Text] [Related]

  • 7. Voice and Stroboscopic Characteristics in Transgender Patients Seeking Gender-Affirming Voice Care.
    Young VN, Yousef A, Zhao NW, Schneider SL.
    Laryngoscope; 2021 May; 131(5):1071-1077. PubMed ID: 32750170
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of hormonal and mental treatments with MMPI in FtM individuals: cross-sectional and longitudinal studies.
    Oda H, Kinoshita T.
    BMC Psychiatry; 2017 Jul 17; 17(1):256. PubMed ID: 28716082
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy: A Narrative Review.
    Streed CG, Harfouch O, Marvel F, Blumenthal RS, Martin SS, Mukherjee M.
    Ann Intern Med; 2017 Aug 15; 167(4):256-267. PubMed ID: 28738421
    [Abstract] [Full Text] [Related]

  • 10. Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.
    Vlot MC, Klink DT, den Heijer M, Blankenstein MA, Rotteveel J, Heijboer AC.
    Bone; 2017 Feb 15; 95():11-19. PubMed ID: 27845262
    [Abstract] [Full Text] [Related]

  • 11. Effects on Voice Fundamental Frequency and Satisfaction with Voice in Trans Men during Testosterone Treatment-A Longitudinal Study.
    Nygren U, Nordenskjöld A, Arver S, Södersten M.
    J Voice; 2016 Nov 15; 30(6):766.e23-766.e34. PubMed ID: 26678122
    [Abstract] [Full Text] [Related]

  • 12. Prospective Evaluation of Self-Reported Aggression in Transgender Persons.
    Defreyne J, T'Sjoen G, Bouman WP, Brewin N, Arcelus J.
    J Sex Med; 2018 May 15; 15(5):768-776. PubMed ID: 29699761
    [Abstract] [Full Text] [Related]

  • 13. Psychometric Evaluation of Adapted Transsexual Voice Questionnaire for Turkish Trans Male Individuals.
    Sirin S, Polat A, Alioglu F.
    J Voice; 2021 Sep 15; 35(5):805.e27-805.e32. PubMed ID: 32088065
    [Abstract] [Full Text] [Related]

  • 14. Pitch Elevation in Male-to-female Transgender Persons-the Würzburg Approach.
    Meister J, Hagen R, Shehata-Dieler W, Kühn H, Kraus F, Kleinsasser N.
    J Voice; 2017 Mar 15; 31(2):244.e7-244.e15. PubMed ID: 27545073
    [Abstract] [Full Text] [Related]

  • 15. Translation, Cultural Adaptation, and Preliminary Evaluation of the Spanish Version of the Transgender Voice Questionnaire for Male-to-Female Transsexuals (TVQ MtF).
    Mora E, Carrillo A, Giribet A, Becerra A, Lucio MJ, Cobeta I.
    J Voice; 2018 Jul 15; 32(4):514.e1-514.e6. PubMed ID: 28599997
    [Abstract] [Full Text] [Related]

  • 16. Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study.
    Vita R, Settineri S, Liotta M, Benvenga S, Trimarchi F.
    Maturitas; 2018 Jan 15; 107():92-96. PubMed ID: 29169588
    [Abstract] [Full Text] [Related]

  • 17. Validation of the German Version of the Transsexual Voice Questionnaire for Male-to-Female Transsexuals.
    Salm S, Hower K, Neumann S, Ansmann L.
    J Voice; 2020 Jan 15; 34(1):68-77. PubMed ID: 30172668
    [Abstract] [Full Text] [Related]

  • 18. Effects of testosterone on the transgender male voice.
    Irwig MS, Childs K, Hancock AB.
    Andrology; 2017 Jan 15; 5(1):107-112. PubMed ID: 27643399
    [Abstract] [Full Text] [Related]

  • 19. An ICF Perspective on Voice-related Quality of Life of American Transgender Women.
    Hancock AB.
    J Voice; 2017 Jan 15; 31(1):115.e1-115.e8. PubMed ID: 27133616
    [Abstract] [Full Text] [Related]

  • 20. Impact of transsexualizing process centers on self-medication of transgender individuals.
    Moraes AMGD, Souza CNPS, Marques LT, Barcelos JFN, Oliveira FB, Bispo RG, Santos RG, Santos ADS, Faria Júnior JAD, Oliveira LMB.
    Rev Saude Publica; 2024 Jan 15; 58():27. PubMed ID: 39082598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.